Chhajlani Pranjal N, Hardikar Hemant
Department of Lab Medicine, Aster Royal Al Raffah Hospital, Muscat, Oman.
Department of Urology, Aster Royal Al Raffah Hospital, Muscat, Oman.
Oman Med J. 2025 Jan 31;40(1):e714. doi: 10.5001/omj.2025.47. eCollection 2025 Jan.
To assess treatment initiatives in symptomatic and asymptomatic urinary tract infection (UTI) cases, identify effective antibiotics based on culture reports, and evaluate secondary factors such as symptoms, urine white blood cells, culture correlation, prevalent microbial flora, empirical antibiotic efficacy, and prevalence of multidrug resistance (MDR).
A retrospective analysis of urological cases with microbial growth on culture was conducted. Data on demographics, symptoms, urinalysis, culture analysis, antibiotic sensitivity, and MDR status were collected and statistically analyzed.
Out of 223 cases included in the study, 191 were symptomatic and 32 were asymptomatic. was the most common pathogenic organism (55.6%). Nitrofurantoin exhibited high efficacy (75.4% in symptomatic and 78.1% in asymptomatic patients), with no significant difference between the two groups in MDR bacteria prevalence ( 0.377) or positive follow-up cultures ( 0.687).
Nitrofurantoin was highly effective for UTIs; however, multidrug-resistant strains remain a concern. With limited access to minimum inhibitory concentration results and culture sensitivity tests during the initial patient visit, physicians prescribing first-line treatments for suspected cases of resistance must carefully evaluate clinical presentation, patient history, and local resistance patterns. Subsequent treatments should be based on culture sensitivity results and clinical guidelines. This study is particularly relevant in the Gulf Cooperation Council region due to its distinct epidemiological and clinical landscape.
评估有症状和无症状尿路感染(UTI)病例的治疗措施,根据培养报告确定有效的抗生素,并评估诸如症状、尿白细胞、培养相关性、常见微生物菌群、经验性抗生素疗效和多重耐药(MDR)患病率等次要因素。
对培养有微生物生长的泌尿外科病例进行回顾性分析。收集有关人口统计学、症状、尿液分析、培养分析、抗生素敏感性和MDR状态的数据并进行统计分析。
在纳入研究的223例病例中,191例有症状,32例无症状。 是最常见的致病生物(55.6%)。呋喃妥因显示出高疗效(有症状患者中为75.4%,无症状患者中为78.1%),两组在MDR细菌患病率(0.377)或培养随访阳性率(0.687)方面无显著差异。
呋喃妥因对UTI非常有效;然而,多重耐药菌株仍然是一个问题。在初次就诊时难以获得最低抑菌浓度结果和培养敏感性试验,为疑似耐药病例开一线治疗药物的医生必须仔细评估临床表现、患者病史和当地耐药模式。后续治疗应基于培养敏感性结果和临床指南。由于其独特的流行病学和临床情况,本研究在海湾合作委员会地区尤为相关。